Solventum Corp (SOLV): Shareholders' Equity
$5.05B
As of 2025-12-31
$4.80B
As of 2026-06-30
-24.5%
3-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $5.05B | +70.6% | 2026-02-27, Balance as of period end |
| 2024-12-31 | $2.96B | -74.6% | 2026-02-27, Balance as of period end |
| 2023-12-31 | $11.67B | -0.6% | 2026-02-27, Balance as of period end |
| 2022-12-31 | $11.74B | n/a | 2025-02-28, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Solventum Corp (SOLV) | 2025-12-31 | $5.05B | +70.6% |
| Baxter International Inc (BAX) | 2025-12-31 | $6.10B | -13.1% |
| ResMed Inc (RMD) | 2026-06-30 | $6.59B | +10.3% |
| Dexcom Inc (DXCM) | 2025-12-31 | $2.75B | +30.6% |
| Boston Scientific Corp (BSX) | 2025-12-31 | $24.47B | +11.2% |
| Becton Dickinson & Co (BDX) | 2025-09-30 | $25.39B | -1.9% |
| MiniMed Group, Inc. (MMED) | 2026-04-24 | $3.61B | +8.4% |
| West Pharmaceutical Services Inc (WST) | 2025-12-31 | $3.18B | +18.4% |
| Globus Medical Inc (GMED) | 2025-12-31 | $4.57B | +9.5% |
Compare SOLV, BAX, RMD, DXCM side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗